Edwards’ Sapien Sales Drive 24% Gain In Q2 Heart Valve Revenue

Edwards Lifesciences' heart valve sales soared 24% in the second quarter from a year ago, to $162.6 million, driven by European sales of its Sapien transcatheter heart valve, the company says